PRIMARY STUDY
The endocannabinoid system as a therapeutic target for schizophrenia: Failures and potentials
Key Findings: CBD may emerge as a promising antipsychotic agent.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Czech Republic
Year of Pub: 2021
Cannabinoids Studied: Cannabidiol (CBD)
Phytocannabinoid Source: Unspecified
Chemotype: Chemotype III
Citation: Seillier A. The endocannabinoid system as a therapeutic target for schizophrenia: Failures and potentials. Neurosci Lett. 2021; 759:136064. doi: 10.1016/j.neulet.2021.136064
Authors: Seillier A
